Representing TEVA on Issuance of USD 2.49 Billion
Congratulations to our client Teva on its successful issuance of $2.49 billion of SLB bonds (Sustainability-Linked Bonds).
This is the second time that Teva has issued bonds with interest rates linked to ESG goals. This transaction demonstrates Teva’s ongoing commitment to promoting ESG goals; the interest paid on the bonds will be linked to Teva’s ESG goals – reducing carbon dioxide emissions and increasing accessibility to medicines in third world countries.
Most of the proceeds from the issuance of the bonds will be used by Teva to finance the purchase of up to $2.5 billion in existing bonds, as announced on February 27, 2023.
This is the second time that Teva has issued bonds with interest rates linked to ESG goals. This transaction demonstrates Teva’s ongoing commitment to promoting ESG goals; the interest paid on the bonds will be linked to Teva’s ESG goals – reducing carbon dioxide emissions and increasing accessibility to medicines in third world countries.
Most of the proceeds from the issuance of the bonds will be used by Teva to finance the purchase of up to $2.5 billion in existing bonds, as announced on February 27, 2023.
Gallery
